S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Che, Pulin ^a   Yang, Youfeng ^b   Han, Xiaosi ^c   Hu, Meng ^a   Sellers, Jeffery C ^d   Londono Joshi, Angelina I ^d   Cai, Guo Qiang ^a   Buchsbaum, Donald J ^d   Christein, John D ^e   Tang, Qinjiu ^f   Chen, Dongquan ^a   Li, Qianjun ^a   Grizzle, William E ^b   Lu, Yin Ying ^g   Ding, Qiang ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d The University of Alabama at Birmingham   (United States)

^e University of Alabama at Birmingham   (United States)

^f National Engineering Research Center of Edible Fungi   (China)

^g BEIJING 302 HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALVASCULIN; CASPASE 3; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; FOCAL ADHESION KINASE; PROTEIN S 100; PROTEIN TYROSINE KINASE; S100A4 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN A;

ANIMAL; ANTAGONISTS AND INHIBITORS; CELL MOTION; CELL PROLIFERATION; DOWN REGULATION; DRUG EFFECTS; FEMALE; GENETICS; HUMAN; METABOLISM; MOUSE; PANCREAS TUMOR; PATHOLOGY; SCID MOUSE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CASPASE 3; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOWN-REGULATION; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MICE; MICE, SCID; PANCREATIC NEOPLASMS; S100 CALCIUM-BINDING PROTEIN A4; S100 PROTEINS; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84938764034     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08453     Document Type: Article

References (57)

1. Ebralidze, A. et al. Isolation and characterization of a gene specifically expressed in different metastatic cells and whose deduced gene product has a high degree of homology to a Ca21-binding protein family. Genes Dev. 3, 1086-1093 (1989).
2. Mazzucchelli, L. Protein S100A4: too long overlooked by pathologists? Am. J. Pathol. 160, 7-13 (2002).
3. Boye, K.&Maelandsmo, G. M. S100A4 and metastasis: a small actor playingmany roles. Am. J. Pathol. 176, 528-535 (2010).
4. Garrett, S. C., Varney, K. M.,Weber, D. J. & Bresnick, A. R. S100A4, amediator of metastasis. J. Biol. Chem. 281, 677-680 (2006).
5. Heizmann, C. W., Fritz, G. & Schafer, B. W. S100 proteins: structure, functions and pathology. Front Biosci. 7, d1356-d1368 (2002).
6. Helfman, D. M., Kim, E. J., Lukanidin, E. & Grigorian, M. The metastasis associated protein S100A4: role in tumour progression and metastasis. Br. J. Cancer 92, 1955-1958 (2005).
7. Ai, K. X., Lu, L. Y., Huang, X. Y., Chen, W. & Zhang, H. Z. Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer. World J. Gastroenterol. 14, 1931-1935 (2008).
8. Saleem, M. et al. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc. Natl. Acad. Sci. U. S. A 103, 14825-14830 (2006).
9. Gupta, S. et al. Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma. J. Clin. Oncol. 21, 106-112 (2003).
10. Kikuchi, N. et al. Nuclear expression of S100A4 is associated with aggressive behavior of epithelial ovarian carcinoma: an important autocrine/paracrine factor in tumor progression. Cancer Sci. 97, 1061-1069 (2006).
11. Lee, W. Y. et al. Expression of S100A4 and Met: potential predictors formetastasis and survival in early-stage breast cancer. Oncology 66, 429-438 (2004).
12. de Silva, R. S. et al. Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer. Clin. Cancer Res. 12, 1192-1200 (2006).
13. Rosty, C. et al. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am. J. Pathol. 160, 45-50 (2002).
14. Oida, Y. et al. Increased S100A4 expression combined with decreased E-cadherin expression predicts a poor outcome of patients with pancreatic cancer. Oncol. Rep. 16, 457-463 (2006).
15. Mishra, S. K., Siddique, H. R.&Saleem,M. S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence. Cancer Metastasis Rev. 31, 163-172 (2012).
16. Mahon, P. C. et al. S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer. Cancer Res. 67, 6786-6795 (2007).
17. Xu, X. et al. Sonic hedgehog-Gli1 signaling pathway regulates the epithelial mesenchymal transition (EMT) by mediating a new target gene, S100A4, in pancreatic cancer cells. PLoS. ONE. 9, e96441 (2014).
18. Li, N., Song, M. M., Chen, X. H., Liu, L. H. & Li, F. S. S100A4 siRNA inhibits human pancreatic cancer cell invasion in vitro. Biomed. Environ. Sci. 25, 465-470 (2012).
19. Owens, L. V. et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res. 55, 2752-2755 (1995).
20. Duxbury, M. S., Ito, H., Zinner, M. J., Ashley, S.W. &Whang, E. E. Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. Surgery 135, 555-562 (2004).
21. Calalb, M. B., Polte, T. R. & Hanks, S. K. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Molecular Cell Biology 15, 954-963 (1995).
22. Parsons, J. T. Focal adhesion kinase: the first ten years. Journal of Cell Science 116, 1409-1416 (2003).
23. Chatzizacharias, N. A. et al. Evaluation of the clinical significance of focal adhesion kinase and SRC expression in human pancreatic ductal adenocarcinoma. Pancreas 39, 930-936 (2010).
24. Ding, Q. et al. Promotion of malignant astrocytoma cell migration by osteopontin expressed in the normal brain: differences in integrin signaling during cell adhesion to osteopontin versus vitronectin. Cancer Res. 62, 5336-5343 (2002).
25. Hecker, T. P., Ding, Q., Rege, T. A., Hanks, S. K. & Gladson, C. L. Overexpression of FAK promotes Ras activity through the formation of a FAK/p120RasGAP complex in malignant astrocytoma cells. Oncogene 23, 3962-3971 (2004).
26. Ding, Q., Gladson, C. L., Wu, H., Hayasaka, H. & Olman, M. A. FAK-related nonkinase inhibits myofibroblast differentiation through differential MAPK activation in a FAK-dependent manner. J. Biol. Chem. 283, 26839-26849 (2008).
27. Chen, H. C., Appeddu, P. A., Isoda, H. & Guan, J. L. Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase. Journal of Biological Chemistry 271, 26329-26334 (1996).
28. Cary, L. A., Chang, J. F. & Guan, J. L. Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J. Cell Sci. 109 (Pt 7), 1787-1794 (1996).
29. Williams, J. C., Wierenga, R. K. & Saraste, M. Insights into Src kinase functions: structural comparisons. Trends Biochem. Sci. 23, 179-184 (1998).
30. Sen, B. & Johnson, F. M. Regulation of SRC family kinases in human cancers. J. Signal. Transduct. 2011, 865819 (2011).
31. Shields, D. J. et al. Oncogenic Ras/Src cooperativity in pancreatic neoplasia. Oncogene 30, 2123-2134 (2011).
32. Thomas, S. M. & Brugge, J. S. Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 13, 513-609 (1997).
33. Wan, M. et al. Yin Yang 1 plays an essential role in breast cancer and negatively regulates p27. Am. J. Pathol. 180, 2120-2133 (2012).
34. Ding, Q. et al. p27Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brain. J. Biol. Chem. 280, 6802-6815 (2005).
35. Olsson, M. & Zhivotovsky, B. Caspases and cancer. Cell Death. Differ. 18, 1441-1449 (2011).
36. Kurokawa, M. & Kornbluth, S. Caspases and kinases in a death grip. Cell 138, 838-854 (2009).
37. Li, J. & Yuan, J. Caspases in apoptosis and beyond. Oncogene 27, 6194-6206 (2008).
38. Orre, L. M. et al. S100A4 interacts with p53 in the nucleus and promotes p53 degradation. Oncogene 32, 5531-5540 (2013).
39. Sui, G. et al. Yin Yang 1 is a negative regulator of p53. Cell 117, 859-872 (2004).
40. McNally, L. R. et al. KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model. Clin. Exp. Metastasis 27, 591-600 (2010).
41. Crawford, Y. & Ferrara, N. VEGF inhibition: insights from preclinical and clinical studies. Cell Tissue Res. 335, 261-269 (2009).
42. Jia, W., Gao, X. J., Zhang, Z. D., Yang, Z. X. & Zhang, G. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF. Eur. Rev. Med. Pharmacol. Sci. 17, 1495-1508 (2013).
43. Jensen, M. M., Jorgensen, J. T., Binderup, T. & Kjaer, A. Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper. BMC. Med. Imaging 8, 16 (2008).
44. Ambartsumian, N. et al. The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor. Oncogene 20, 4685-4695 (2001).
45. Hernandez, J. L. et al. Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody. PLoS. ONE. 8, e72480 (2013).
46. Schlaepfer, D. D., Hauck, C. R. & Sieg, D. J. Signaling through focal adhesion kinase. Prog. Biophys. Mol. Biol. 71, 435-478 (1999).
47. Xing, Z. et al. Direct interaction of v-Src with the focal adhesion kinase mediated by the Src SH2 domain. Molecular Cell Biology 5, 413-421 (1994).
48. Renouf, D. J. et al. A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer. Invest New Drugs 30, 779-786 (2012).
49. Derosier, L. C. et al. TRA-8 anti-DR5 monoclonal antibody and gemcitabine induce apoptosis and inhibit radiologically validated orthotopic pancreatic tumor growth. Mol. Cancer Ther. 6, 3198-3207 (2007).
50. Akisawa, N., Nishimori, I., Iwamura, T., Onishi, S. & Hollingsworth, M. A. High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential. Biochem. Biophys. Res. Commun. 258, 395-400 (1999).
51. Tomayko, M. M. & Reynolds, C. P. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother. Pharmacol. 24, 148-154 (1989).
52. Euhus, D. M., Hudd, C., LaRegina, M. C. & Johnson, F. E. Tumormeasurement in the nude mouse. J. Surg. Oncol. 31, 229-234 (1986).
53. Cai, G. Q. et al. Neuronal Wiskott-Aldrich syndrome protein (N-WASP) is critical for formation of alpha-smooth muscle actin filaments during myofibroblast differentiation. Am. J. Physiol Lung Cell Mol. Physiol 303, L692-L702 (2012).
54. Ding, Q., Stewart, J. Jr., Olman, M. A., Klobe, M. R. &Gladson, C. L. The pattern of enhancement of Src kinase activity on platelet-derived growth factor stimulation of glioblastoma cells is affected by the integrin engaged. J. Biol. Chem. 278, 39882-39891 (2003).
55. Cai, G. Q. et al. Downregulation of FAK-related non-kinase mediates the migratory phenotype of human fibrotic lung fibroblasts. Exp. Cell Res. 316, 1600-1609 (2010).
56. Ding, Q. et al. FAK-related nonkinase is a multifunctional negative regulator of pulmonary fibrosis. Am. J. Pathol. 182, 1572-1584 (2013).
57. Han, X. et al. TGF-beta1 up-regulates paxillin protein expression in malignant astrocytoma cells: requirement for a fibronectin substrate. Oncogene 20, 7976-7986 (2001).